Literature DB >> 15879108

Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.

Kei Yasuda1, Philipp Yu, Carsten J Kirschning, Beatrix Schlatter, Frank Schmitz, Antje Heit, Stefan Bauer, Hubertus Hochrein, Hermann Wagner.   

Abstract

TLRs discriminate foreign from self via their specificity for pathogen-derived invariant ligands, an example being TLR9 recognizing bacterial unmethylated CpG motifs. In this study we report that endosomal translocation of CpG DNA via the natural endocytotic pathway is inefficient and highly saturable, whereas endosomal translocation of DNA complexed to the cationic lipid N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate (DOTAP) is not. Interestingly, DOTAP-mediated enhanced endosomal translocation of otherwise nonstimulatory vertebrate DNA or of certain noncanonical CpG motifs triggers robust dendritic cell activation in terms of both up-regulation of CD40/CD69 and cytokine production, such as type I IFN and IL-6. We report that the stimulatory activity of phosphorothioated noncanonical CpG oligodeoxynucleotides is TLR9 dependent, whereas phosphodiester DNA, such as vertebrate DNA, in addition trigger TLR9-independent pathways. We propose that the inefficiency of the natural route for DNA internalization hinders low affinity TLR9 ligands in endosomes to reach threshold concentrations required for TLR9 activation. Endosomal compartmentalization of TLR9 may thus reflect an evolutionary strategy to avoid TLR9 activation by self-DNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879108     DOI: 10.4049/jimmunol.174.10.6129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  91 in total

1.  A non-coding cationic lipid DNA complex produces lasting anti-leukemic effects.

Authors:  Nikki Keasey; Zachary Herse; Stella Chang; Denny H Liggitt; Marla Lay; Jeffery Fairman; David F Claxton
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

Review 2.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

Review 3.  Molecular characterization of human plasmacytoid dendritic cells.

Authors:  Wei Cao
Journal:  J Clin Immunol       Date:  2009-03-06       Impact factor: 8.317

4.  Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.

Authors:  Sibylle Tluk; Marion Jurk; Alexandra Forsbach; Risini Weeratna; Ulrike Samulowitz; Arthur M Krieg; Stefan Bauer; Jörg Vollmer
Journal:  Int Immunol       Date:  2009-03-30       Impact factor: 4.823

5.  Sequence independent interferon-alpha induction by multimerized phosphodiester DNA depends on spatial regulation of Toll-like receptor-9 activation in plasmacytoid dendritic cells.

Authors:  Tobias Haas; Frank Schmitz; Antje Heit; Hermann Wagner
Journal:  Immunology       Date:  2008-11-15       Impact factor: 7.397

6.  Cytoplasmic dsRNA induces the expression of OCT3/4 and NANOG mRNAs in differentiated human cells.

Authors:  Guanming Wang; Takahisa Kouwaki; Kazuki Mugikura; Masaaki Okamoto; Hiromi Takaki; Kenji Funami; Tsukasa Seya; Hiroyuki Oshiumi
Journal:  J Biol Chem       Date:  2019-10-15       Impact factor: 5.157

Review 7.  Intracellular DNA recognition.

Authors:  Veit Hornung; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

8.  CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.

Authors:  Yong-Mei Guo; Keiko Ishii; Makoto Hirokawa; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Junsuke Yamashita; Toshiaki Ohteki; Nobuyuki Onai; Kazuyoshi Kawakami; Weiguo Xiao; Kenichi Sawada
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

9.  Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response.

Authors:  Katalin Kis-Toth; Attila Szanto; To-Ha Thai; George C Tsokos
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

10.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.